Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Liu L, Zhao N, Xu W, Sheng Z, Wang L.
Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma.

J Hematol Oncol 2016;
9 (01) 54

Bibliographische Angaben herunterladen

Aufrufen in: